Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...
CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...
Health In Tech announced new partnerships that it says will allow it to introduce a new self-funded health plan. 1 The ...
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...
The government agency says X no longer suits its communication needs.
A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...
Paul Howe, chief commercial officer at Protega Pharma, discusses how regulatory agencies are updating their policies based on the presence of abuse-deterrent medications.
Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...